NASDAQ · ADMA
ADMA Biologics Inc
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ADMA: Nov 04, 2026
ADMA Biologics Inc Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $0.19. The reported EPS for the same quarter last year was $0.16.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.19 | $0.19 | $0.19 | 1 |
| Dec 2026 | $0.22 | $0.22 | $0.22 | 1 |
| Mar 2027 | $0.17 | $0.17 | $0.17 | 1 |
| Jun 2027 | $0.20 | $0.20 | $0.20 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks- Zacks · Oct 29, 8:00 AM EDTInvestors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to KnowAdma Biologics (ADMA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- Zacks · Oct 20, 4:50 PM EDTAdma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth KnowingAdma Biologics (ADMA) closed the most recent trading day at $11.24, moving +1.49% from the previous trading session.
- Zacks · Oct 12, 8:30 AM EDTWall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
- Zacks · Oct 9, 6:51 AM EDTIntellia Therapeutics (NTLA) Soars 7.6%: Is Further Upside Left in the Stock?Intellia Therapeutics (NTLA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Zacks · Oct 8, 4:50 PM EDTAdma Biologics (ADMA) Advances While Market Declines: Some Information for InvestorsIn the latest trading session, Adma Biologics (ADMA) closed at $10.33, marking a +1.87% move from the previous day.
- Zacks · Oct 8, 8:00 AM EDTADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should KnowRecently, Zacks.com users have been paying close attention to Adma Biologics (ADMA). This makes it worthwhile to examine what the stock has in store.
- Zacks · Sep 29, 4:45 PM EDTHere's Why Adma Biologics (ADMA) Fell More Than Broader MarketIn the most recent trading session, Adma Biologics (ADMA) closed at $10, indicating a -1.24% shift from the previous trading day.
- Zacks · Sep 24, 4:50 PM EDTWhy Adma Biologics (ADMA) Dipped More Than Broader Market TodayAdma Biologics (ADMA) closed at $9.52 in the latest trading session, marking a -1.86% move from the prior day.
- Zacks · Sep 24, 8:30 AM EDTWall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
- Zacks · Sep 18, 5:50 PM EDTAdma Biologics (ADMA) Outpaces Stock Market Gains: What You Should KnowAdma Biologics (ADMA) closed the most recent trading day at $9.13, moving +2.01% from the previous trading session.
- Zacks · Sep 11, 5:45 PM EDTAdma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to KnowAdma Biologics (ADMA) reached $9.23 at the closing of the latest trading day, reflecting a -1.7% change compared to its last close.
- Zacks · Sep 10, 5:50 PM EDTAdma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to KnowAdma Biologics (ADMA) closed at $9.36 in the latest trading session, marking a -1.01% move from the prior day.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for ADMA Biologics Inc from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.